Clinical Trials
2 trialsNCT01768338 2023-02-10
Recombinant Human IL-18 and Ofatumumab After PBSCT for Lymphoma
Indiana University
Phase 1 Completed
NCT02277392 2018-09-27
A Phase-I, Dose Escalation Study of Recombinant Human Interleukin-18 (Sb-485232) Combined With Adoptive Transfer of Vaccine-Primed CD3/CD28-Costimulated Autologous T-Cells Following Lymphodepletion for Adult Patients With Recurrent Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Abramson Cancer Center at Penn Medicine
Phase 1 Withdrawn